Eurobio Scientific Société anonyme (EPA:ALERS)
20.80
+0.80 (4.00%)
Aug 3, 2026, 12:54 PM CET
EPA:ALERS Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 168.6 | 154.56 | 82.28 | 305.07 | 167.43 | |
Revenue Growth | 9.08% | 87.85% | -73.03% | 82.21% | -55.67% |
Cost of Revenue | 91.75 | 82.99 | 48.1 | 81.66 | 71.32 |
Gross Profit | 76.85 | 71.57 | 34.18 | 71.24 | 96.11 |
Selling, General & Admin | 52.99 | 45.46 | 24 | 31 | 28.19 |
Depreciation & Amortization Expenses | 3.78 | 3.75 | 6.73 | 5.9 | 4.09 |
Research & Development | - | - | - | 3.47 | - |
Other Operating Expenses | 9.33 | 9.03 | - | - | - |
Total Operating Expenses | 66.1 | 58.24 | 30.72 | 40.37 | 32.28 |
Operating Income | 10.74 | 13.33 | 12.27 | 30.87 | 70.04 |
Interest Income | -2.94 | -5.67 | 2.18 | 0.11 | 1.55 |
Interest Expense | - | - | -4.77 | -1.29 | -1.62 |
Other Non-Operating Income (Expense) | - | -1.38 | -0.71 | -0.67 | 0.11 |
Total Non-Operating Income (Expense) | -2.94 | -7.05 | -3.3 | -1.86 | 0.04 |
Pretax Income | 7.81 | 6.28 | 9.68 | 29.68 | 69.97 |
Provision for Income Taxes | -2.94 | -2.29 | 0.83 | -4.75 | 7.74 |
Net Income | 4.87 | 4 | 8.14 | 24.94 | 62.34 |
Net Income to Common | 4.87 | 4 | 8.14 | 24.94 | 62.34 |
Net Income Growth | 21.69% | -50.88% | -67.36% | -60.00% | -15.15% |
Shares Outstanding (Basic) | 10 | 10 | 11 | 11 | 11 |
Shares Outstanding (Diluted) | 10 | 10 | 11 | 11 | 11 |
Shares Change | - | -8.63% | -1.40% | 4.59% | -3.35% |
EPS (Basic) | 0.47 | 0.39 | 0.43 | 2.20 | 5.58 |
EPS (Diluted) | 0.47 | 0.39 | 0.43 | 2.20 | 5.57 |
EPS Growth | 20.51% | -9.30% | -80.45% | -60.50% | -14.70% |
Free Cash Flow | 6.28 | 13.45 | 22.71 | 40.24 | 64.07 |
Free Cash Flow Growth | -53.28% | -40.80% | -43.55% | -37.19% | 21.73% |
Free Cash Flow Per Share | 0.61 | 1.31 | 2.02 | 3.54 | 5.89 |
Gross Margin | 45.58% | 46.30% | 41.55% | 23.35% | 57.40% |
Operating Margin | 6.37% | 8.63% | 14.91% | 10.12% | 41.83% |
Profit Margin | 2.89% | 2.59% | 9.89% | 8.17% | 37.24% |
FCF Margin | 3.73% | 8.70% | 27.60% | 13.19% | 38.27% |
EBITDA | 27.68 | 30.39 | 26.52 | 40.09 | 76.98 |
EBITDA Margin | 16.42% | 19.66% | 32.23% | 13.14% | 45.98% |
EBIT | 10.74 | 13.33 | 12.27 | 30.87 | 70.04 |
EBIT Margin | 6.37% | 8.63% | 14.91% | 10.12% | 41.83% |
Effective Tax Rate | -37.67% | -36.39% | 8.57% | -15.99% | 11.06% |